Form 4 for SNA Snap-on
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001127602-23-004984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-13 | 2023-02-09 | SNA | Pagliari Aldo John | CFO, SVP - Fin | M - OptEx | $109.43 | +14.3K | 84.8K | +20% | +$1.56M |
| DM | 2023-02-13 | 2023-02-09 | SNA | Pagliari Aldo John | CFO, SVP - Fin | S - Sale+OE | $251.90 | -7,030 | 80.5K | -8% | -$1.77M |
| D | 2023-02-13 | 2023-02-09 | SNA | Pagliari Aldo John | CFO, SVP - Fin | F - Tax | $249.26 | -2,021 | 82.8K | -2% | -$503.8K |
| DM | 2023-02-13 | 2023-02-09 | SNA | Pagliari Aldo John | CFO, SVP - Fin | A - Grant | $0.00 | +14.7K | 4,300 | New | $0 |
| DM | 2023-02-13 | 2023-02-09 | SNA | Pagliari Aldo John | CFO, SVP - Fin | M - OptEx | — | -14.3K | 23.0K | -38% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 10,000 | $109.43 | 87,541.29 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-09 | S | D | 2,190 | $250.23 | 85,351.29 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $249.95 to $250.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 3 | Common | Common Stock | 2023-02-09 | S | D | 1,700 | $251.71 | 83,651.29 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $251.32 to $252.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 4 | Common | Common Stock | 2023-02-09 | S | D | 1,934 | $252.85 | 81,717.29 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $252.35 to $253.335. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 5 | Common | Common Stock | 2023-02-09 | S | D | 1,206 | $253.70 | 80,511.29 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $253.40 to $254.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 6 | Common | Common Stock | 2023-02-09 | M | A | 4,300 | — | 84,811.29 | D | — | — | (F6) Based on Company performance during the 2020-2022 period, approximately 151.4% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). |
| 7 | Common | Common Stock | 2023-02-09 | F | D | 2,021 | $249.26 | 82,790.29 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-02-09 | A | A | 7,850 | $0.00 | 7,850 | D | $249.26 · 2024-02-09 to 2033-02-09 | 7,850 Common Stock | (F12) The transaction was an option grant. Accordingly, the reporting person did not pay a price to obtain the option. (F11) Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. |
| 9 | Derivative | Performance Units | 2023-02-09 | A | A | 3,586 | $0.00 | 3,586 | D | — · — to — | 3,586 Common Stock | (F10) 1 for 1. (F14) If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. |
| 10 | Derivative | Restricted Stock Units | 2023-02-09 | A | A | 1,793 | $0.00 | 1,793 | D | — · 2026-02-09 to 2026-02-09 | 1,793 Common Stock | (F10) 1 for 1. (F13) The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. |
| 11 | Derivative | Performance Units | 2023-02-09 | M | D | 4,300 | — | 0 | D | — · — to — | 4,300 Common Stock | (F6) Based on Company performance during the 2020-2022 period, approximately 151.4% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). (F10) 1 for 1. |
| 12 | Derivative | Performance Units | 2023-02-09 | A | A | 1,460 | — | 4,300 | D | — · — to — | 1,460 Common Stock | (F6) Based on Company performance during the 2020-2022 period, approximately 151.4% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). (F10) 1 for 1. |
| 13 | Derivative | Stock Option (Right to Buy) | 2023-02-09 | M | D | 10,000 | — | 23,000 | D | $109.43 · — to 2024-02-13 | 10,000 Common Stock | (F9) Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan. (F8) Option fully vested. |